Adapt Pharma Operations Limited v. Teva Pharmaceuticals USA, Inc., Appeal No. 2020-2106 (Fed. Cir. Feb. 10, 2022) -
In our Case of the Week, the Court of Appeals for the Federal Circuit, in both the majority opinion and...more
2/15/2022
/ Appeals ,
En Banc Review ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
Motion To Seal ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Prior Art ,
Remand ,
Third-Party ,
Vacated
The Federal Circuit issued numerous precedential opinions last week, two of which answered long simmering questions about inter partes reviews (IPRs). Below we discuss a case addressing whether admissions of prior art in the...more
2/8/2022
/ Abstract Ideas ,
Appeals ,
Claim Construction ,
Damages ,
Estoppel ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Preliminary Injunctions ,
Prior Art ,
Remand ,
Settlement Agreements
University of Strathclyde v. Clear-Vu Lighting LLC, Appeal No. 2021-2243 (Fed. Cir. Nov. 4, 2021) -
In this week’s Case of the Week, the Federal Circuit reversed an inter partes review decision finding claims directed to...more
11/9/2021
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Dismissals ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art
Bio-Rad Laboratories, Inc. v. International Trade Commission, Appeal Nos. 2020-1475, -1605 (Fed. Cir. May 28, 2021)-
In this week’s Case of the Week, the Federal Circuit considered an appeal from the International Trade...more
PATENT CASE OF THE WEEK -
Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Appeal Nos. 2018-2414, et al. (Fed. Cir. Jan. 7, 2020) -
In this appeal from Markman and summary judgment opinions by the district court in a...more
1/14/2020
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Amgen ,
Claim Construction ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prior Art
PATENT CASE OF THE WEEK -
Persion Pharms. LLC v. Alvogen Malta Operations Ltd., Appeal No. 2018-2361 (Fed. Cir. Dec. 27, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a district court judgment...more
12/31/2019
/ Appeals ,
Evidence ,
Food and Drug Administration (FDA) ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prior Art ,
Reaffirmation
PATENT CASE OF THE WEEK -
Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2018-1329, et al. (Fed. Cir. Nov. 13, 2019) -
This week’s Case of the Week strikes close to home,...more
11/19/2019
/ Abstract Ideas ,
Design Patent ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101 ,
Venue
PATENT CASE OF THE WEEK -
Telefonaktiebolaget LM Ericsson v. TCL Corporation, Appeal Nos. 2017-2381, -2385 (Fed. Cir. Nov. 7, 2019) -
In this week’s Case of the Week, the Federal Circuit reviewed two inter partes...more
Curver Luxembourg, SARL v. Home Expressions Inc., Appeal No. 2018-2214 (Fed. Cir. Sept. 12, 2019)
In a significant case in the field of design patents, the Federal Circuit clarified the scope of design patent infringement...more
9/17/2019
/ Acquisitions ,
Antitrust Violations ,
Appeals ,
Collateral Estoppel ,
Counterclaims ,
Design Patent ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Monopolization ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Sherman Act ,
Summary Judgment ,
The Clayton Act
Arthrex, Inc. v. Smith & Nephew, Inc., Appeal No. 2018-1584 (Fed. Cir. Aug. 21, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed an inter partes review decision of the Patent Trial and Appeal Board,...more
8/27/2019
/ Administrative Procedure Act ,
Claim Construction ,
Enhanced Damages ,
Evidence ,
Inter Partes Review (IPR) Proceeding ,
Inventive Concept Test ,
Motivation to Combine ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Reversal ,
Vacated
PATENT CASE OF THE WEEK -
Celgene Corporation v. Laura A. Peter, Appeal Nos. 2018-1167, -1168, -1169, -1171 (Fed. Cir. July 30, 2019) -
In this week’s Case of the Week, the Federal Circuit held that the retroactive...more
8/6/2019
/ Dismissals ,
Doctrine of Equivalents ,
Estoppel ,
Failure To State A Claim ,
Fifth Amendment ,
Inter Partes Reexamination ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
USPTO
PATENT CASE OF THE WEEK -
General Electric Co. v. United Techs. Corp., Appeal No. 2017-2497 (Fed. Cir. July 10, 2019) -
The Case of the Week focuses on standing to bring an appeal of an adverse decision by the PTAB in...more
7/16/2019
/ Administrative Procedure Act ,
Appeals ,
Article III ,
Claim Construction ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Standing ,
Vacated
PATENT CASE OF THE WEEK -
In re: Global IP Holdings LLC, Appeal No. 2018-1426 (Fed. Cir. July 5, 2019) -
The Federal Circuit vacated and remanded a decision of the Patent Trial and Appeal Board (“PTAB”) upholding an...more
7/9/2019
/ Improper Venue ,
Intellectual Property Protection ,
Inventors ,
Life Sciences ,
Metadata ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Principal Place of Business ,
Prior Art ,
Remand ,
Section 101 ,
Section 112 ,
Vacated
The Supreme Court and the Federal Circuit issued three precedential opinions this week concerning matters of first impression involving inter partes reviews, two of which concern the status of government actors in the...more
PATENT CASE OF THE WEEK -
Papst Licensing GMBH & Co. KG v. Samsung Electronics America, Inc., Appeal No. 2018-1777 (Fed. Cir. May 23, 2019) -
In a sternly-worded decision this week, the Federal Circuit held claims to...more
5/29/2019
/ Abuse of Discretion ,
Appeals ,
Claim Construction ,
Claim Limitations ,
Claim Preclusion ,
Computer-Related Inventions ,
Inter Partes Review (IPR) Proceeding ,
Means-Plus-Function ,
Obviousness ,
On-Sale Bar ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Testimony
PATENT CASE OF THE WEEK -
VirnetX Inc. v. Apple, Inc., Appeal Nos. 2017-2490, -2494 (Fed. Cir. Dec. 10, 2018)
The Federal Circuit affirmed two final written decisions of the Patent Trial and Appeal Board (“PTAB”), which...more
12/18/2018
/ America Invents Act ,
Appeals ,
Attorney's Fees ,
Claim Construction ,
Collateral Estoppel ,
Final Written Decisions ,
Intellectual Property Protection ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Printed Publications ,
Prior Art
Acceleration Bay, LLC v. Activision Blizzard Inc., Appeal Nos. 2017-2084, -2085, -2095, -2096, -2097, -2098, -2099, -2117, 2118 (Fed. Cir. Nov. 6, 2018)
In appeals of six inter partes review final decisions on three...more
11/13/2018
/ Appeals ,
Assignor Estoppel ,
Cross-Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Remand ,
Reversal
PATENT CASE OF THE WEEK -
Data Engine Technologies, LLC v. Google LLC, Appeal No. 2017-1135 (Fed. Cir. Oct. 9, 2018) -
In one of two Section 101 cases this week, the Federal Circuit affirmed-in-part, reversed-in-part, and...more
10/16/2018
/ Abstract Ideas ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
Summary Judgment
PATENT CASE OF THE WEEK -
Power Integrations, Inc. v. Fairchild Semiconductor Int’l, Inc., Appeal Nos. 2016-2691, 2017-1875 (Fed. Cir. Sept. 20, 2018)
In a reissued, slightly altered version of a July 3, 2018 decision,...more
9/25/2018
/ Appeals ,
Burden of Persuasion ,
Burden-Shifting ,
Damages ,
Intellectual Property Protection ,
Nonobvious ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Petition For Rehearing ,
Prior Art ,
Purchasers ,
Reversal ,
Vacated
PATENT CASE OF THE WEEK -
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., Appeal Nos. 2017-2078, -2134 (Fed. Cir. Sept. 10, 2018)
The Federal Circuit affirmed the district court’s ruling following a bench trial,...more
9/18/2018
/ Bench Trial ,
De Novo Standard of Review ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Nonobvious ,
Obviousness ,
Patent Applications ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Preponderance of the Evidence ,
Printed Publications ,
Prior Art
PATENT CASE OF THE WEEK -
Polara Engineering Inc. v. Campbell Company, Appeal Nos. 2017-1974, -2033 (Fed. Cir. July 10, 2018)
In this wide-ranging opinion, the Court provided a rare and lengthy opinion on the public use...more
7/18/2018
/ Claim Construction ,
En Banc Review ,
Enhanced Damages ,
Experimental Use Exception ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Public Use ,
Trade Secrets
Medtronic, Inc. v. Mark A. Barry, Appeal Nos. 2017-1169, -1170 (Fed. Cir. June 11, 2018) -
The Court affirmed-in-part and vacated-in-part a PTAB decision finding that petitioner Medtronic, Inc. had failed to prove that...more
6/19/2018
/ Attorney's Fees ,
Lack of Jurisdiction ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
Vacated
D Three Enterprises, LLC v. SunModo Corporation, Appeal Nos. 2017-1909, -1910 (Fed. Cir. May 21, 2018) -
The Court affirmed a grant of summary judgment of invalidity in favor of patent infringement defendants, based on a...more
5/30/2018
/ Anticipation ,
Antitrust Violations ,
Appeals ,
Breach of Contract ,
Double Patent ,
Indefiniteness ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Royalties ,
Patents ,
Prior Art ,
Reissue Patents ,
Summary Judgment ,
Willful Infringement ,
Written Descriptions
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., Appeal Nos. 2016-2616, -2656 (Fed. Cir. May 16, 2018) -
In an appeal from a inter partes review, the Federal Circuit reviewed a PTAB obviousness...more
5/22/2018
/ Burden of Proof ,
Claim Construction ,
Claim Limitations ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Patents ,
Prior Art ,
Section 101 ,
Venue ,
Writ of Mandamus
Oracle America, Inc. v. Google LLC, Appeal No. 2017-1118, -1202 (Fed. Cir. 2018) -
In an appeal from a jury trial, the Federal Circuit reversed the District Court’s decision denying Oracle’s motion for JMOL and remanded...more
4/3/2018
/ Android ,
Appeals ,
Copyright ,
Copyright Infringement ,
Damages ,
Fair Use ,
Intellectual Property Protection ,
Java ,
JMOL ,
Jury Trial ,
Obviousness ,
Oracle v Google ,
Patent Applications ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
Reversal ,
Standard of Review ,
Transformative Use